Skip to content

Author

Stuti Shah

We have 4 of 11 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Incremental prognostic value of late gadolinium enhancement in hypertrophic cardiomyopathy in a large contemporary cohort

Late gadolinium enhancement (LGE) on cardiac magnetic resonance (CMR) reflects myocardial fibrosis and has been associated with adverse outcomes in hypertrophic cardiomyopathy (HCM). We sought to measure its incremental prognostic value beyond established clinical and phenotypic variables in a large contemporary HCM...

H. Sheashaa, S. Keen, S. Shah et al. · 0 citations
Open access Oct 2026

Incremental prognostic value of extracellular volume fraction in hypertrophic cardiomyopathy in a large contemporary cohort

Left ventricular (LV) myocardial extracellular volume (ECV), derived from cardiac magnetic resonance (CMR) T1 mapping, reflects diffuse interstitial fibrosis and has emerged as a quantitative marker of adverse myocardial remodeling in hypertrophic cardiomyopathy (HCM). We aimed to determine the independent prognostic...

S. Shah, S. Keen, H. Sheashaa et al. · 0 citations
Open access Sep 2026

GLP-1 Analogues and Long-term Outcomes in Adults with Obesity and Elevated CRP: A Real-world Matched Cohort Study.

Obesity is frequently accompanied by low-grade systemic inflammation and increased cardiovascular risk. We evaluated whether glucagon-like peptide-1 receptor agonist (GLP-1 RA) exposure was associated with improved long-term outcomes among adults with obesity and C-reactive protein (CRP) levels of 3-10 mg/L. Using the...

Stuti Shah, M. Abusafia, Hesham Sheashaa et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.